S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US6596701B1 · kind B1 · utility
31Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1998 |
| Grant date | Jul 22, 2003 |
| Priority date | — |
| Expiry date | Mar 16, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6893
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new paradigm of disease centers around the metabolic pathways of S-adenosyl-L-methionine (SAM), the intermediates of these pathways and other metabolic pathways influenced by the SAM pathways. Methods are provided to analyze and modulate SAM pathways associated with a disease or condition. Such methods permit identification and utilization of diagnostic and therapeutic protocols and agents for such disease states and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.